Normalized yield of high molecular weight DNA. by Ella Messner (14493059)

Subjects:

Percentage of high molecular weight DNA. by Ella Messner (14493059)

Subjects:

Experimental Design. by Ella Messner (14493059)

Subjects:

The effect of preservative treatments on average percentages of high molecular weight DNA (%HMW) and average yields of high molecular weight DNA normalized by tissue weight (nY) fo... by Ella Messner (14493059)

Subjects:

Good knowledge, good perception and acceptance of COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Knowledge and acceptance of COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Association between Sociodemographic and level of knowledge, perception, and acceptance of the respondents. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Logistics regression COVID-19 vaccine predictors. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Perception towards COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

The level of knowledge of the COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Demographic information of respondents (N = 1,143). by Adaobi Uchenna Mosanya (20384248)

Subjects:

Association between sociodemographic and level of knowledge, perception and acceptance of the respondents. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3. by Anneli Peolsson (7867601)

Subjects:

The CONSORT flow diagram. by Anneli Peolsson (7867601)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Subjects:

Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness. by Anneli Peolsson (7867601)

Subjects:

Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects: